Ftse Mib
34.603,61
-0,64%
DAX
18.726,76
-0,21%
S&P 500
5.321,41
0,25%
NASDAQ
16.832,62
0,22%
Bitcoin
70.208,05
-1,74%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Aeolus Pharmaceuticals Inc (CE) (AOLS) Aeolus Pharmaceuticals Inc (CE) (AOLS) Notizie

AOLS

Aeolus Pharmaceuticals (CE) (AOLS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:AOLS
DataOraFonteTitoloSimboloCompagnia
22/12/201722:53Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
14/08/201723:09Edgar (US Regulatory)Quarterly Report (10-q)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
24/03/201716:51Edgar (US Regulatory)Current Report Filing (8-k)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
14/02/201717:17Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
30/01/201723:06Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
30/12/201622:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
20/12/201623:28Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
20/12/201623:25Edgar (US Regulatory)Annual Report (10-k)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
16/05/201623:09Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
19/04/201623:10Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
23/03/201621:49Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
16/02/201612:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
12/02/201622:32Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
18/12/201512:05Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
15/12/201521:24Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
17/02/201522:32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
01/07/201413:30MarketwiredAeolus Announces Additional Data Demonstrating Efficacy of AEOL 10150 as a Medical Countermeasure Against Exposure to Nerve A...USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
18/06/201416:39MarketwiredAeolus Announces Publication of Data Demonstrating Efficacy of AEOL 10150 in Animal CEES Model of Mustard Gas Skin ExposureUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
02/06/201422:32Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
02/06/201414:00MarketwiredAeolus Pharmateucticals to Present at LD Micro Invitational ConferenceUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
16/05/201401:03MarketwiredAeolus Announces Second Quarter Fiscal Year 2014 Financial Results and Achievements in Lung-ARS Development ProgramUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
28/03/201417:24Edgar (US Regulatory)Registration of Securities by Certain Investment Companies. Declaration of Election Rule 24f-2 Notice (24f-2nt)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
28/03/201417:24Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
14/02/201423:30MarketwiredAeolus Announces First Quarter Fiscal Year 2014 Financial ResultsUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
14/02/201423:00Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
14/02/201423:00Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
13/02/201413:30MarketwiredAeolus Announces Process Improvements and Positive 18 Month Stability Results for AEOL 10150 in New FormulationUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
10/02/201413:30MarketwiredAeolus Announces Publication of Data Demonstrating Efficacy of AEOL 10150 in Animal Model of Lung Radiation Exposure; Models ...USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
23/01/201416:52MarketwiredAeolus Receives Orphan Drug Designation for AEOL 10150 From U.S. FDAUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
23/12/201314:00MarketwiredAeolus Announces Fiscal Year 2013 Financial ResultsUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:AOLS

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
G
Generali
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TIT
Telecom Italia
BIT
TEN
Tenaris
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
TITR
Telecom Italia
BIT
CPR
Davide Campari
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network